Amanote Research
Register
Sign In
P3.04-28 Can Ipilimumab Restore Immune Response in Advanced NSCLC After Progression on Anti PD1/PDL1 Agents?
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.1735
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
M. Sternschuss
N. Peled
E. Dudnik
O. Rotem
A. Zer
Publisher
Elsevier BV